DGX · Quest Diagnostics Inc

$238.50 +2.66 (+1.13%) At close · Aug 6

Market Cap

$26.32B

110.37M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
James E. Davis	CEO	$1,250,000	—	$8,762,861	$2,999,873	$2,205,844	$279,901	$15,498,479
Sam A. Samad	CFO	$693,269	—	$2,190,967	$749,742	$710,358	$82,805	$4,427,141
Catherine T. Doherty	Executive Vice President, Regional Businesses	$643,269	—	$1,679,674	$574,876	$615,184	$49,943	$3,562,946
Karthik Kuppusamy	Senior Vice President, Clinical Solutions	$568,269	—	$1,095,483	$374,893	$475,526	$65,652	$2,579,823
Michael E. Prevoznik	General Counsel	$550,000	—	$1,132,015	$387,343	$438,323	$55,912	$2,563,593

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
James E. Davis	CEO	$1,250,000	—	$8,239,724	$2,843,630	$1,811,250	$260,258	$14,404,862
Sam A. Samad	CFO	$668,269	—	$2,028,350	$699,881	$580,993	$90,971	$4,068,464
Catherine T. Doherty	Executive Vice President, Regional Businesses	$618,269	—	$1,593,772	$549,821	$477,798	$46,420	$3,286,080
Michael E. Prevoznik	General Counsel	$550,000	—	$1,086,688	$374,874	$371,910	$45,174	$2,428,646
Karthik Kuppusamy	Senior Vice President, Clinical Solutions	$543,269	—	$978,040	$337,359	$367,359	$51,664	$2,277,691

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
James E. Davis	CEO	$1,175,000	—	$7,290,745	$2,499,848	$1,361,531	$346,710	$12,673,834
Sam A. Samad	CFO	$650,000	—	$1,968,594	$674,882	$451,913	$229,725	$3,975,114
Catherine T. Doherty	Executive Vice President, Regional Businesses	$600,000	—	$1,604,093	$549,846	$370,800	$34,105	$3,158,844
Michael E. Prevoznik	General Counsel	$542,500	—	$1,020,747	$349,948	$293,357	$45,368	$2,251,920
Karthik Kuppusamy	Senior Vice President, Clinical Solutions	$512,500	—	$875,090	$299,811	$290,991	$36,813	$2,015,205

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Rusckowski	CEO	$1,278,846	—	$8,350,579	$2,874,884	$2,856,686	$317,168	$15,678,164
James E. Davis	CEO	$805,769	—	$8,542,446	$1,249,946	$1,082,853	$202,012	$11,883,027
Sam A. Samad	CFO	$300,000	$1,200,000	$3,330,906	$624,865	$725,693	$87,518	$6,268,982
Carrie Eglinton Manner	President and CEO	$270,673	—	$3,392,590	$499,910	—	$48,358	$4,211,531
Catherine T. Doherty	Executive Vice President, Regional Businesses	$594,231	—	$1,234,571	$424,854	$580,500	$39,154	$2,873,309
Mark Guinan	CFO	$398,462	—	$835,070	$801,102	$444,862	$61,913	$2,541,409
Michael E. Prevoznik	General Counsel	$535,000	—	$1,016,786	$349,798	$487,796	$53,920	$2,443,300
Patrick Plewman	Senior Vice President, Diagnostic Services Former Executive Officers	$512,104	—	$728,227	$249,758	$441,276	$48,579	$1,979,943

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Rusckowski	CEO	$1,238,462	—	$7,631,057	$2,624,978	$2,695,511	$367,810	$14,557,818
Mark Guinan	CFO	$643,077	—	$1,567,373	$689,871	$839,794	$77,448	$3,817,563
James E. Davis	CEO	$625,385	—	$1,567,373	$689,871	$816,690	$72,022	$3,771,341
Carrie Eglinton Manner	President and CEO	$600,000	—	$1,362,859	$599,962	$696,480	$65,375	$3,324,676
Catherine T. Doherty	Executive Vice President, Regional Businesses	$575,000	—	$1,090,337	$479,939	$625,744	$40,563	$2,811,583

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Rusckowski	CEO	$1,107,692	—	$7,279,883	$2,500,020	$3,000,000	$194,013	$14,081,608
Mark Guinan	CFO	$591,385	—	$1,569,547	$690,012	$905,883	$46,597	$3,803,424
James E. Davis	CEO	$577,231	—	$1,569,547	$690,012	$815,050	$42,866	$3,694,706
Carrie Eglinton Manner	President and CEO	$566,538	—	$1,364,907	$600,011	$707,493	$40,032	$3,278,981
Manuel O. Mendez	Senior Vice President and Chief Commercial Officer	$572,308	—	$199,999	$200,004	—	$11,615	$983,926

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Manuel O. Mendez	Senior Vice President and Chief Commercial Officer	$147,962	—	$1,316,584	$177,746	$480,000	—	$2,122,292

Executive changes

Person	Role	Change	Effective	Filed
Timothy Wentworth	director	Appointed	2026-03-09	2026-03-12
Robert B. Carter	Director	Appointed	2024-05-16	2024-05-21

Key facts CIK 1022079 CUSIP 74834L100 13F (30d) 578 filings 551 filers Visit website Investor relations